Clinical Trials in Rheumatology in Ahmedabad
Dr. Dhaiwat Shukla has actively participated in multiple national and international clinical trials in the field of rheumatology and autoimmune diseases. His experience includes working as Principal Investigator, Co-Investigator, and Study Physician in research studies related to Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Osteoporosis, Ankylosing Spondylitis, Systemic Sclerosis, and other immune-mediated disorders. These studies help bring innovative and evidence-based treatments closer to patients while contributing to advancements in rheumatology care.
| Trial indication | Drug | CTRI No |
|---|---|---|
| SLE(Minor organ) | Cenerimod | |
| SLE minor organ | ESK-001 | |
| SLE minor organ | BRAVE study Baricitinib phase 3 | |
| Systemic Sclerosis | Anifrolumab | |
| Osteoporosis | Teriparatide | |
| Osteoporosis | Denosumab | |
| Osteoporosis | Teriparatide | |
| SLE with Lupus nephritis | Zeptomipzomib | |
| SLE with Lupus Nephritis | Anifrolumab | |
| Ankylosing Spondylitis | Adalimumab | |
| Psoriatic Arthritis | Ixekizumab | |
| Psoriatic arthritis | Apremilast Phase 4 | |
| Psoriasis | Calcipotriol+betam ethasone topical therapy | |
| Spondyloarthropathy | CLASSIC study (MRI criteria for SpA) | |
| Spondyloarthropathy | PerSPA (Observational) | |
| Rheumatoid arthritis | Otilimab (ContRAst-1) Phase 3/PK | |
| Rheumatoid Arthritis | Adalimumab | |
| Rheumatoid Arthritis | ------- | |
| Rheumatoid Arthritis | VELLORA | |
| Osteoarthritis | Denatured Collagen | |
| Diabetes mellitus | Orforglipron | |
| Diabetes Mellitus type-2 | Deglusterol | |
| Diabetes Mellitus type 2 | Thymoquinone | |
| Diabetes mellitus type II | Retatrutide | |
| Diabetes Mellitus type II | Dulaglutide | |
| Yellow Fever | Vaccine | |
| Recurrent Staph Aureus Infection | Vaccine | |
| HIV | HRF-10071 | |
| HIV | HRF-10071 | |
| Rabies | Vaccine/Anti Rabies Immunoglobulin | |
| Dengue | Dengue mAb | |
| COVID 19(Vaccine) | m-RNA vaccine as a booster | |
| COVID-19 | Guduchyadi/Tinos pora Cordifolia | |
| COVID 19 | --------- | |
| COVID 19 | mAb Cocktail ZRC3308 | |
| COVID 19 | Molnupiravir | |
| COVID 19 | Ashwagandha | |
| COVID 19 | Chlorphylin | |
| COVID 19 | Inosine Phase 3 | |
| COVID 19 | Thymoquinone Phase 2/3 | |
| COVID 19 | Thymoquinone Phase 2/3 | |
| Respiratory Viral infection | Equivir | |
| Anaemia | Ferric Carboxy Maltose | |
| Chronic Constipation | Linaclotide | |
| Post Operative Pain | Paracetamol |